UBS lowered the firm’s price target on Exxon Mobil (XOM) to $138 from $142 and keeps a Buy rating on the shares ahead of the company’s December 6 Corporate Plan webcast. While additional details on the Pioneer (PXD) acquisition may be limited, the firm sees the event reinforcing its view that Exxon is best positioned to outperform the sector this upcycle. Driving UBS’s positive outlook is Exxon’s visible upstream growth above peer levels, Downstream/Chemicals capacity additions improving underlying EPS power, Low Carbon investments providing long-term growth potential, and balance sheet strength enabling higher capital returns at current oil prices.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PXD:
- Argus double downgrades Pioneer Natural, sees no competing bids
- Pioneer Natural downgraded to Sell from Buy at Argus
- Pioneer Natural price target lowered to $243 from $258 at Stifel
- Pioneer Natural price target lowered to $238 from $255 at Truist
- Pioneer Natural downgraded to Neutral from Buy at Mizuho